Is limiting rather than abolishing prescription charges the answer?

Pharmaceutical Journal

Volumn 276, Issue 7394, 2006, Pages 388-389

  Schafheutle, Ellen ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONSULTATION; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; LOWEST INCOME GROUP; MEDICAL FEE; MEDICAL LEAVE; NATIONAL HEALTH SERVICE; PRESCRIPTION; REVIEW; UNITED KINGDOM;

EID: 33645743969     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Scottish Executive. Review of NHS prescription charges and exemption arrangements in Scotland. Consultation. Published 25 January 2006. Available at: www.scotland.gov.uk/ (accessed 3 March 2006).
2. Schafheutle EI, Hassell K, Seston EM, Noyce PR. Non-dispensing of NHS prescriptions in community pharmacies. International Journal of Pharmacy Practice 2002;10:11-5.
3. Schafheutle EI, Hassell K, Noyce PR, Weiss MC. Access to medicines: cost as an influence on the views and behaviour of patients. Health and Social Care in the Community 2002;10:187-95.
4. Schafheutle EI, Hassell K, Noyce PR. Coping with prescription charges in the UK. International Journal of Pharmacy Practice 2004;12:239-46.
5. Atella V, Schafheutle E, Noyce P, Hassell K. Affordability of medicines and patients'cost reduction behaviours: empirical evidence based on SUR estimates from Italy and the UK. Applied Health Economics and Health Policy 2005;4:23-35.
6. BMA. Funding - prescription charges (briefing paper). British Medical Association, 2005. Available at: www.bma.org.uk/ap.nsf/Content/ FundingPrescriptionCharges (accessed 13 March 2006).
7. Schafheutle EI, Cantrill JA, Nicolson M, Noyce PR. Insights into the choice between self-medication and a doctor's prescription: a study of hay fever sufferers. International Journal of Pharmacy Practice 1996;4:156-61.
8. Payne K, Ryan-Woolley BM, Noyce PR. Role of consumer attributes in predicting the impact of medicines deregulation on National Health Service prescribing in the United Kingdom. International Journal of Pharmacy Practice 1998;6:150-8.
9. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scoff S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-9.
10. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P. Effect of limiting Medicaid drug-reimbursement benefits on the use of psychotrapic agents and acute mental health services by patients with schizophrenia. New England Journal of Medicine 1994;331:650-5.
11. Schafheutle EI. How does the cost of the prescription charge matter to asthma patients? 12th Health Services Research and Pharmacy Practice Conference 2006 34 April; Bath. (See www.hsrpp.org.uk)